Contineum Therapeutics, Inc. (CTNM)
NASDAQ: CTNM · Real-Time Price · USD
14.48
-0.32 (-2.16%)
At close: Feb 5, 2026, 4:00 PM EST
14.12
-0.36 (-2.49%)
After-hours: Feb 5, 2026, 7:46 PM EST
Contineum Therapeutics Market Cap
Contineum Therapeutics has a market cap or net worth of $528.95 million as of February 5, 2026. Its market cap has increased by 83.05% in one year.
Market Cap
528.95M
Enterprise Value
352.03M
1-Year Change
83.05%
Ranking
Category
Stock Price
$14.48
Market Cap Chart
Since the IPO on April 5, 2024, Contineum Therapeutics's market cap has increased from $402.09M to $528.95M, an increase of 31.55%. That is a compound annual growth rate of 16.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 5, 2026 | 528.95M | 26.68% |
| Dec 31, 2025 | 417.53M | 10.56% |
| Dec 31, 2024 | 377.64M | -6.08% |
| Apr 5, 2024 | 402.09M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evommune | 582.57M |
| Replimune Group | 578.91M |
| Keros Therapeutics | 562.71M |
| LB Pharmaceuticals | 553.29M |
| REGENXBIO | 549.77M |
| Lexeo Therapeutics | 548.86M |
| Lyell Immunopharma | 547.46M |
| Lexicon Pharmaceuticals | 534.87M |